This Article Full Text (PDF) All Versions of this Article: 1352458507082604v1 14/2/278    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kimiskidis, V. Articles by Fassas, A. Search for Related Content PubMed PubMed Citation Articles by Kimiskidis, V. Articles by Fassas, A. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Multiple Sclerosis Social Bookmarking                         What's this?

Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome

Department of Neurology , Aristotle University of Thessaloniki, George Papanikolaou Hospital, Thessaloniki, 570 10 Greece, kimiskid{at}med.auth.gr

I. Sakellari

Department of Haematology, Bone Marrow Transplantation Unit, George Papanikolaou Hospital, Thessaloniki, 570 10 Greece

V. Tsimourtou

Department of Neurology , Aristotle University of Thessaloniki, George Papanikolaou Hospital, Thessaloniki, 570 10 Greece

V. Kapina

Department of Neurology , Aristotle University of Thessaloniki, George Papanikolaou Hospital, Thessaloniki, 570 10 Greece

S. Papagiannopoulos

Department of Neurology , Aristotle University of Thessaloniki, George Papanikolaou Hospital, Thessaloniki, 570 10 Greece

D. Kazis

Department of Neurology , Aristotle University of Thessaloniki, George Papanikolaou Hospital, Thessaloniki, 570 10 Greece

N. Vlaikidis

Department of Neurology , Aristotle University of Thessaloniki, George Papanikolaou Hospital, Thessaloniki, 570 10 Greece

A. Anagnostopoulos

Department of Haematology, Bone Marrow Transplantation Unit, George Papanikolaou Hospital, Thessaloniki, 570 10 Greece

A. Fassas

Department of Haematology, Bone Marrow Transplantation Unit, George Papanikolaou Hospital, Thessaloniki, 570 10 Greece

Malignant multiple sclerosis (MS) is a rare but clinically important subtype of MS characterized by the rapid development of significant disability in the early stages of the disease process. These patients are refractory to conventional immunomodulatory agents and the mainstay of their treatment is plasmapheresis or immunosuppression with mitoxantrone, cyclophosphamide, cladribine or, lately, bone marrow transplantation. We report on the case of a 17-year old patient with malignant MS who was treated with high-dose chemotherapy plus anti-thymocyte globulin followed by autologous stem cell transplantation. This intervention resulted in an impressive and long-lasting clinical and radiological response. It is concluded that intensive immunosuppression followed by autologous stem cell transplantation is a viable therapeutic option in patients with malignant MS unresponsive to conventional forms of treatment. Multiple Sclerosis 2008; 17 : 278—283. http://msj.sagepub.com

Key Words: autologous stem-cell transplantation • malignant multiple sclerosis

This version was published on March 1, 2008

Multiple Sclerosis, Vol. 14, No. 2, 278-283 (2008)
DOI: 10.1177/1352458507082604


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J Fagius, J Lundgren, and G Oberg Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation Multiple Sclerosis, February 1, 2009; 15(2): 229 - 237. [Abstract] [PDF]